Gregory S. Kopf
Greg is the Director of Research and Development for Contraceptive Technology Innovation within Global Health, Population and Nutrition at FHI360 in Durham, NC. His basic scientific research interests include the biology of gametogenesis, fertilization and early pre-implantation development, and his translational and clinical interests have focused on both infertility and contraception.
In 1982, Greg was the Celso Ramon Garcia Professor of Reproductive Biology in Obstetrics and Gynecology at the University of Pennsylvania School of Medicine. In 2001, he became the Assistant Vice President (and later Interim Vice President) of Discovery, Women’s Health & Bone at Wyeth Pharmaceuticals where he focused on contraceptive development. From 2008-2013 he was the Associate Vice Chancellor for Research Administration at the University of Kansas School of Medicine (KUMC), the Executive Director of the KUMC Research Institute, Inc., and Research Professor of Molecular & Integrative Physiology at KUMC.
Greg has served on the editorial boards of several journals; federal advisory committees for the NIH, NSF, and Institute of Medicine; and has served on boards of directors for several non-profit and for-profit organizations/businesses. He currently serves on the National Advisory Child Health and Human Development Council of the Eunice Kennedy Shriver National Institute of Child Health and Human Development.
Greg obtained his B.A. (Biology) from The College of Wooster and his Ph.D. (Physiology) from Vanderbilt University School of Medicine. He completed his postdoctoral training at the University of California, San Diego.